We sat down with Brad Marder, MD, co-author of the study, #Pegloticase Therapy in Gout Patients Undergoing Dialysis: A USRDS Database Study. Data suggests that pegloticase is successful in the treatment of dialysis patients with uncontrolled #gout.https://t.co/MO6gR3aTgI

— Rheumatology Network (@RheumatologyNet) April 14, 2021

Just accepted in Arthritis & Rheumatology:

Epidemiology of scleritis in the United Kingdom from 1997 to 2018: Population‐based analysis of 11 million patients and association between scleritis and infectious and immune‐mediated inflammatory diseasehttps://t.co/rOGjZ61uGk

— ACR_Journals (@ACR_Journals) April 15, 2021

Patients with #psoriaticarthritis (PsA) treated with #guselkumab resulted in higher percentages of resolved #enthesitis by Week 24 and maintained those results through 1 year when compared with a placebo.https://t.co/xvW93ChWND

— Rheumatology Network (@RheumatologyNet) April 15, 2021

This weekend is @LupusAcademy 2021. I'm so excited to be attending with my wonderful friends @PamelaLutalo and Chai Ling.Although we cannot be in Florence this year,we will enjoy a stellar #virtual congress with the global #lupus community from our offices in Singapore and London pic.twitter.com/KQnwt9naRE

— Antigoni Grigoriou (@antigonig) April 16, 2021

Researchers have found a link between periodontitis and cardiovascular disease #CVD in individuals with rheumatoid arthritis.

Read more in the April #Arthritis & #Rheumatology Editor's Choice article for free here: https://t.co/fsDAIF7o2J@ACR_Journals pic.twitter.com/6sQlkg5sAQ

— Wiley Health (@Wiley_Health) April 15, 2021